Prophylactic Breast Bud Radiotherapy for Patients Taking Bicalutamide: Should This Still Be Practised for Patients with Prostate Cancer?
Prophylactic breast bud radiotherapy is used to prevent gynaecomastia and mastalgia in patients with prostate cancer who are being treated with antiandrogen and oestrogen therapy. Here a case is presented of a patient who developed soft-tissue sarcoma of the breast subsequent to breast bud radiother...
Saved in:
| Main Authors: | R. Lewis, A. Cassoni, H. Payne |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Case Reports in Oncological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2012/239269 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cysteamine–bicalutamide combination therapy corrects proximal tubule phenotype in cystinosis
by: Amer Jamalpoor, et al.
Published: (2021-06-01) -
Patient-reported outcomes of rezvilutamide versus bicalutamide in combination with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer patients (CHART): a randomized, phase 3 study
by: Hongkai Wang, et al.
Published: (2024-12-01) -
Cost-effectiveness analysis of rezvilutamide versus bicalutamide and androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer: a Markov’s model-based evaluation
by: Juan Hong, et al.
Published: (2025-05-01) -
Prophylactic routine posterior pericardiotomy: Should we perform it in every patient?Central Message
by: Vasily I. Kaleda, MD, et al.
Published: (2022-08-01) -
Carboxylated Mesoporous Carbon Nanoparticles as Bicalutamide Carriers with Improved Biopharmaceutical and Chemo-Photothermal Characteristics
by: Teodora Popova, et al.
Published: (2025-07-01)